课题基金 / 基金详情

Characterization of the redox control of HIV-Tat proteostasis by cellular NQO1

Characterization of the redox control of HIV-Tat proteostasis by cellular NQO1
细胞 NQO1 对 HIV-Tat 蛋白质稳态氧化还原控制的表征
批准号:
9695502
负责人:
Mario A. Bianchet
金额:
$24.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-15 至 2020-08-31

项目摘要

项目成果

Mario A. Bianchet的其他基金

相似基金

相关文献

中文摘要
翻译
1)项目摘要/摘要 潜伏的人类免疫缺陷病毒(HIV)持续存在于休眠感染细胞池(称为“病毒库”)中。 不受联合抗逆转录病毒疗法(购物车)影响的患者。难以接近的解剖隔间 像大脑和肠道这样的治疗药物是病毒的庇护所,藏匿在储藏室或保持低级别 感染。在病毒学抑制的个体中,这些水库中的潜伏前病毒随机变得 在CART停止时激活,重新播种感染。艾滋病毒间接感染长寿的脑细胞 损伤神经元。持续的脑部感染会导致一系列被称为HIV相关的综合征 神经认知障碍(手)。CART降低了严重手的发生率,如HIV相关 痴呆症;然而,较轻的手部形式仍然很普遍,其发病率与 种族/族裔少数群体和相当大的社会经济影响。受感染的人将释放病毒神经毒素 与CART无关的细胞和CART药物本身引起的氧化应激都是重要的因素 在手中。所有这些都支持有效抑制艾滋病毒感染的必要性。禁用集成 使用基因编辑的普罗鲁斯虽然很有前途,但仍然是一个有风险的命题,并有几个主要问题, 例如,在将基因编辑转移到临床之前,必须解决逃逸突变的产生 使用。感染细胞的根除/灭菌可能会对中枢神经系统敏感/药物产生不良后果- 受保护的环境。通过引入深度延迟(“阻塞和锁定”)策略来使储集层失活是 更适合大脑,因为它们不需要激活、杀死和清除受感染的脑细胞 然而,所有这些策略都需要对前病毒活动进行一定程度的控制,以解释 对了解病毒潜伏机制有相当大的兴趣。一种由 反式转录激活因子(TAT)蛋白的表达调节前病毒的高效转录。塔特 细胞水平低于或超过阈值会导致前病毒进入或退出潜伏期。一种药理上的 可利用的反馈机制,涉及病毒调节蛋白REV和宿主细胞保护酶 NQO1,稳定病毒所需的TAT(蛋白稳定)的细胞水平。NQO1还可以稳定细胞 维持细胞健康和应对病毒感染所必需的许多蛋白质水平。我们的 目的是研究这一特性不佳的蛋白平衡机制,以促进其靶向性。我们是 建议研究:(1)涉及的物理络合物,它们的缔合热力学和结构, 使用生物物理方法纯化蛋白质;以及(2)修饰NQO1活性对病毒潜伏期的影响, 细胞外TAT或CART对神经元的损伤,以及对氧化和展开的非靶点影响 蛋白质应激反应。通过破坏TAT蛋白平衡来控制前病毒转录可能是 病毒活性操纵在根除或终生灭活病毒方面的显著协同作用 此外,我们还开发了多种神经保护疗法,以减少中枢神经系统中TAT的有害影响。
英文摘要
1) Project Summary/Abstract Latent human immunodeficiency virus (HIV) persists in pools of dormant infected cells (called “viral reservoirs”) that are unaffected by combined antiretroviral therapies (cARTs). Anatomic compartments hard to reach with therapeutic drugs as the brain and gut are viral sanctuaries harboring reservoirs or maintaining low-grade infections. In virologically suppressed individuals, latent proviruses in those reservoirs become stochastically active upon the discontinuation of cART, reseeding the infection. HIV infects long-lived brain cells indirectly damaging neurons. The action of a persistent brain infection causes a set of syndromes called HIV associated neurocognitive disorders (HAND). cART decreased the incidence of severe HAND such as HIV-associated dementia; however milder forms of HAND still are prevalent, having a disproportionate incidence on racial/ethnic minorities and a considerable socioeconomic impact. Viral neurotoxins to be released by infected cells despite cART and the oxidative stress caused by the cART drugs themselves are both significant factors in HAND. All the above support the need for efficient suppression of the HIV infection. Disable integrated proviruses using gene editing, although promising, is still a risky proposition and has several major issues, such as the generation of escape mutations, which must be resolved before moving gene-editing to clinical use. Eradication/sterilization of the infected cells could have adverse outcomes in the CNS sensitive/drug- protected environment. The reservoirs inactivation by inducing deep-latency (“block and lock”) strategies are more suitable for the brain because they do not require activate, killing, and clearing the infected brain cells Nevertheless, all of these strategies require a level of control on the provirus activity explaining the considerable interest in understanding viral latency mechanisms. A feedback mechanism driven by the expression of the trans-activator of transcription (Tat) protein regulates productive provirus transcription. Tat cellular levels under or over a threshold result in provirus entry or exit from latency. A pharmacologically exploitable feedback mechanism, involving the viral regulatory protein Rev and a host cytoprotective enzyme NQO1, stabilizes the cellular level of Tat (proteostasis) required for the virus. NQO1 also stabilizes cellular levels of many proteins essential for the cell well-being maintenance and to cope with the viral infection. Our objective is to investigate this poorly characterized proteostasis mechanism to facilitate its targeting. We are proposing to investigate: (1) the physical complexes involved, their association thermodynamics, and structure, using biophysical methods with purified proteins; and (2) the effect of modify NQO1 activity on viral latency, on the damage to neurons produced by extracellular Tat or cART, and off-target effects on oxidative- and unfolde protein stress responses. Controlling proviral transcription by disrupting Tat proteostasis has the potential to be a significantly synergistic part of viral activity manipulation in the eradication or lifelong inactivation of viral reservoirs, as well as of neuroprotective therapies that decrease the detrimental effects of Tat in the CNS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of I- transport by the Na+/l- symporter (NIS)
  • 批准号:
    10683934
  • 项目类别:
  • 资助金额:
    $44.41万
  • 财政年份:
    2016
  • 负责人:
    Mario A. Bianchet
  • 依托单位:
Mechanism of I- transport by the Na+/l- symporter (NIS)
  • 批准号:
    10219677
  • 项目类别:
  • 资助金额:
    $47.22万
  • 财政年份:
    2016
  • 负责人:
    Mario A. Bianchet
  • 依托单位:
Mechanism of I- transport by the Na+/l- symporter (NIS)
  • 批准号:
    10580384
  • 项目类别:
  • 资助金额:
    $7.47万
  • 财政年份:
    2016
  • 负责人:
    Mario A. Bianchet
  • 依托单位:
Mechanism of I- transport by the Na+/l- symporter (NIS)
  • 批准号:
    10436880
  • 项目类别:
  • 资助金额:
    $45.0万
  • 财政年份:
    2016
  • 负责人:
    Mario A. Bianchet
  • 依托单位:
海外基金